Institutional investors increased stakes in Merck & Co. during Q4, with Good Life Advisors LLC purchasing additional shares; Merck reported Q4 EPS of $0.03, exceeding estimates by $0.12.
Institutional investors increased their stakes in Merck & Co. during Q4, with Good Life Advisors LLC purchasing an additional 1,993 shares. Merck reported Q4 earnings of $0.03 EPS, surpassing analysts' consensus estimates of ($0.09) by $0.12, and had revenue of $14.63 billion. Institutional investors currently own 76.07% of the company's stock. Several other large investors, including Ruedi Wealth Management Inc., TFO Wealth Partners LLC, and Ameliora Wealth Management Ltd, also made changes to their positions in MRK.
March 28, 2024
18 Articles